Ocular Surface in Patients With Soft Contact Lenses

NCT04244643 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 524

Last updated 2024-07-16

No results posted yet for this study

Summary

Contact lenses modify the structure of the tear film by biophysical and biochemical interactions. These changes may explain more common dry eye symptoms and may sometimes cause lens failure or discontinuation.

In recent years, the investigators have various objective non-invasive methods of tear film evaluation such as the non-invasive break up time, interferometry, and tears meniscus height. These measurements are performed in clinical practice during consultation by devices such as LACRYDIAG.

The improvement of lens comfort requires a better knowledge of the ocular surface in patients with contact lenses. But currently none of these objective parameters have been accurately described.

Therefore, the investigators would like to build a database to describe the different parameters of ocular surface in patients with soft contact lenses.

Conditions

  • Ocular Surface

Interventions

OTHER

data collection

Data collected from patient records * Demographic data: date of birth, sex, city of birth * Contact lenses: laboratory, brand, model, wearing time before the exam, opening date of the blister, solution of contact lenses, material, renewal time * Refraction * Dry eye disease: Ocular Surface Disease Index (OSDI) score * LACRYDIAG data: Non-Invasive Break-Up Time (NIBUT), interferometry and tears meniscus height

Sponsors & Collaborators

  • Société Française des Ophtalmologistes Adaptateurs de Lentilles de Contact

    collaborator UNKNOWN
  • Centre Hospitalier Universitaire de Saint Etienne

    lead OTHER

Principal Investigators

  • Marie Caroline TRONE · CHU de Saint Etienne

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-18
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04244643 on ClinicalTrials.gov